Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Véronique Deparis"'
Publikováno v:
Biotechnology progressREFERENCES. 37(4)
A challenging aspect with the use of protein hydrolysates in commercial manufacturing processes of recombinant therapeutic proteins is their impacts on the protein production due to a lack of understanding of batch-to-batch variability. Soy hydrolysa
Publikováno v:
Biotechnology Progress. 37
Events of viral contaminations occurring during the production of biopharmaceuticals have been publicly reported by the biopharmaceutical industry. Upstream raw materials were often identified as the potential source of contamination. Viral contamina
Autor:
Alex Eon-Duval, Thomas Solacroup, Hervé Broly, Marco Barbafieri, Ralf Gleixner, Yolande Rouiller, Véronique Deparis
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 81(2)
The production bioreactor step of an Fc-Fusion protein manufacturing cell culture process was characterized following Quality by Design principles. Using scientific knowledge derived from the literature and process knowledge gathered during developme
Publikováno v:
Animal Cell Technology: From Target to Market ISBN: 9789401038973
Recombinant soluble human α1,3/4FucosyltransferaseIII was produced with two Sf9 insect cell lines adapted to grow either in serum-containing (SCM) or in serum-free medium (SFM). The optimal time of infection to obtain the highest Fuc-TIII activity i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcecaee5304fd6bf1033e6f3f6c223c5
https://doi.org/10.1007/978-94-010-0369-8_21
https://doi.org/10.1007/978-94-010-0369-8_21